Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

834 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genetic polymorphisms: importance for response to HMG-CoA reductase inhibitors.
Maitland-van der Zee AH, Klungel OH, Stricker BH, Monique Verschuren WM, Kastelein JJ, Leufkens HG, de Boer A. Maitland-van der Zee AH, et al. Among authors: stricker bh. Atherosclerosis. 2002 Aug;163(2):213-22. doi: 10.1016/s0021-9150(01)00725-0. Atherosclerosis. 2002. PMID: 12052467 Review.
Adherence to and dosing of beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitors in the general population differs according to apolipoprotein E-genotypes.
Maitland-van der Zee AH, Stricker BH, Klungel OH, Mantel-Teeuwisse AK, Kastelein JJ, Hofman A, Leufkens HG, van Duijn CM, de Boer A. Maitland-van der Zee AH, et al. Among authors: stricker bh. Pharmacogenetics. 2003 Apr;13(4):219-23. doi: 10.1097/00008571-200304000-00006. Pharmacogenetics. 2003. PMID: 12668918
Cholesterol and age-related macular degeneration: is there a link?
van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, van Duijn CM, Stricker BH, de Jong PT. van Leeuwen R, et al. Among authors: stricker bh. Am J Ophthalmol. 2004 Apr;137(4):750-2. doi: 10.1016/j.ajo.2003.09.015. Am J Ophthalmol. 2004. PMID: 15059717
Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitor therapy in men.
Maitland-van der Zee AH, Klungel OH, Stricker BH, Veenstra DL, Kastelein JJ, Hofman A, Witteman JC, Leufkens HG, van Duijn CM, de Boer A. Maitland-van der Zee AH, et al. Among authors: stricker bh. Pharmacogenetics. 2004 Jan;14(1):53-60. doi: 10.1097/00008571-200401000-00006. Pharmacogenetics. 2004. PMID: 15128051
834 results